Roche expected to extend Illumina offer as-is; Bayer puts ex-CEO forward to fill chairman's seat;

@FiercePharma: Mead-Johnson and Danone team up to rival Nestle for Pfizer's nutrition unit, Reuters reports. News | Follow @FiercePharma

> Analysts expect Roche ($RHHBY) to extend its offer for gene-sequencing firm Illumina ($ILMN) at the same price--$5.7 billion in cash--when the current bid expires later today. Report

> Bayer nominated its former CEO, Werner Wenning, to take over as chairman of the board, replacing Manfred Schneider, who plans to leave Sept. 30. Article

> The FDA issued a warning letter to Germany's Fresenius, citing problems at a U.S. plant operated by subsidiary APP Pharmaceuticals ($APPX). Story

> The aid group Medecins Sans Frontieres is once again pressing Novartis ($NVS) to drop its long-running legal protest against a provision of Indian patent law, saying it could end in restricting access to affordable drugs. Report

> CVS ($CVS) isn't liable for selling prescription data to pharmaceutical companies, a judge ruled, ending a class action filed by a Pennsylvania pension fund. Report

> Clorox ($CLX) CEO Don Knauss is targeting acquisitions of healthcare products or services to build up his company's new business in the health arena. News

> Seven U.S. states joined Roman Catholic groups and two individuals to sue the Obama administration over new rules requiring healthcare coverage for free birth control. More

Biotech News

@FierceBiotech: Heart muscle-cell gel can treat cardiac damage, maybe carry drugs as well--FierceBiotechResearch. Article | Follow @FierceBiotech

@JohnCFierce: Russia VC, now in Boston, will build clinical trial services infrastructure in Russia. They are throwing $$ around. Release | Follow @JohnCFierce

@RyanMFierce: Actelion and Auxilium have inked a deal for the development Xiaflex in Canada, Brazil, Australia and Mexico. More | Follow @RyanMFierce

@FierceMedDev: $WMGI saw Q4 net sales decline 8% vs. prior-year period ($126.9M vs $138.3M same period of 2010). Release | Follow @FierceMedDev

> Chelsea Therapeutics surges on FDA panel nod for Northera. News

> Forest Labs notches victory en route to FDA ruling on COPD drug. More

> Biotech VC climate warmer than some thought. Story

> Russian biotech VC and Quintiles to join forces on pharma services startups. Article

> GSK steps in to back Canadian vaccine project. Item

And Finally... Eating citrus fruit might help to lower women's risk of stroke, researchers found. Release

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.